We are live on ! Find out more
O

OppenheimerFunds Portfolio holdings

AUM $80.4B
1-Year Est. Return 15.1%
This Fund
S&P 500
This Quarter Est. Return
+1.29%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
AUM
$87.2B
AUM Growth
-$2.36B
Cap. Flow
-$2.46B
Cap. Flow %
-2.82%
Top 10 Hldgs %
13.2%
Holding
1,014
New
117
Increased
412
Reduced
346
Closed
83

Sector Composition

Rank Sector Weight
1 Energy 16.99%
2 Financials 14.34%
3 Healthcare 13.06%
4 Consumer Discretionary 12.54%
5 Communication Services 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMC icon
101
Vulcan Materials
VMC
$36.3B
$234M 0.27%
2,791,642
-691,482
-20% -$60.3M
HEP
102
DELISTED
Holly Energy Partners, L.P.
HEP
$234M 0.27%
6,652,515
+3,520
+0.1% +$117K
UPS icon
103
United Parcel Service
UPS
$97.6B
$231M 0.27%
2,387,870
+229,050
+11% +$22.8M
RTX icon
104
RTX Corp
RTX
$287B
$231M 0.26%
3,305,797
-7,235
-0.2% -$531K
DCP
105
DELISTED
DCP Midstream, LP
DCP
$229M 0.26%
7,475,641
-416,251
-5% -$15.6M
ZBH icon
106
Zimmer Biomet
ZBH
$17.7B
$228M 0.26%
2,147,833
+26,121
+1% +$2.89M
AON icon
107
Aon
AON
$77.3B
$226M 0.26%
2,263,489
-22,039
-1% -$2.21M
BSX icon
108
Boston Scientific
BSX
$65.8B
$225M 0.26%
12,696,157
+4,038,548
+47% +$72.2M
CSC
109
DELISTED
Computer Sciences
CSC
$222M 0.25%
8,020,408
+1,798,022
+29% +$50.4M
CLDX icon
110
Celldex Therapeutics
CLDX
$2.77B
$222M 0.25%
586,322
-22,022
-4% -$8.75M
MET icon
111
MetLife
MET
$61B
$220M 0.25%
4,418,228
+30,696
+0.7% +$1.45M
CELG
112
DELISTED
Celgene Corp
CELG
$215M 0.25%
1,859,630
-4,700
-0.3% -$537K
VRTX icon
113
Vertex Pharmaceuticals
VRTX
$121B
$209M 0.24%
1,689,012
-205,550
-11% -$25.9M
ABEV icon
114
Ambev
ABEV
$47.3B
$207M 0.24%
33,964,208
-43,431,507
-56% -$268M
ABT icon
115
Abbott
ABT
$180B
$207M 0.24%
+4,216,930
New +$202M
NKE icon
116
Nike
NKE
$61.9B
$206M 0.24%
3,807,388
+495,660
+15% +$25.4M
GM icon
117
General Motors
GM
$74.7B
$206M 0.24%
6,168,193
-2,321,099
-27% -$82.8M
BRK.B icon
118
Berkshire Hathaway Class B
BRK.B
$1.07T
$203M 0.23%
1,493,445
+818
+0.1% +$117K
CIB icon
119
Grupo Cibest SA
CIB
$20.4B
$202M 0.23%
4,690,385
+21,180
+0.5% +$911K
SCHW
120
Charles Schwab
SCHW
$177B
$196M 0.23%
6,013,450
+403,410
+7% +$12.7M
ZTS icon
121
Zoetis
ZTS
$31.6B
$196M 0.22%
4,062,549
+727,036
+22% +$34.7M
AMAT icon
122
Applied Materials
AMAT
$426B
$194M 0.22%
10,115,743
+98,657
+1% +$2.02M
CNC icon
123
Centene
CNC
$31.3B
$194M 0.22%
4,833,928
-82,540
-2% -$2.96M
AMZN icon
124
Amazon
AMZN
$2.5T
$191M 0.22%
8,822,980
+7,314,840
+485% +$153M
TFCFA
125
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$191M 0.22%
5,878,237
-1,423,374
-19% -$47.9M

Similar funds

OppenheimerFunds's Q2 2015 Portfolio in Review

As of Q2 2015, OppenheimerFunds held 1,014 positions worth $87.2B, down 2.6% from $89.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

OppenheimerFunds's Q2 2015 filing shows 117 new, 412 increased, 346 reduced and 83 closed positions. Its largest new stake was Trip.com Group: 12,596,284 shares worth $457M. The largest sale was Baidu, an estimated $856M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • OppenheimerFunds's largest Q2 2015 buy was Trip.com Group: 12,596,284 shares worth $457M.
  • OppenheimerFunds added most to Alibaba in Q2 2015, an estimated $561M increase.
  • OppenheimerFunds's biggest Q2 2015 reduction was Baidu, cutting an estimated $856M.
  • OppenheimerFunds fully exited REGENCY ENERGY PARTNERS LP COMMON UTS REP LIMITED PART INTS in Q2 2015, selling an estimated $711M.
  • OppenheimerFunds's ten largest holdings make up 13% of its $87.2B portfolio in Q2 2015.
  • OppenheimerFunds opened 117 new positions and closed 83 in Q2 2015.
  • OppenheimerFunds's portfolio value fell 2.6% quarter-over-quarter to $87.2B.

Based on OppenheimerFunds's 13F filing for Q2 2015, filed 6 Aug 2015.